Chronic Obstructive Pulmonary Disease (COPD) - Wake Research

Chronic Obstructive Pulmonary Disease (COPD)

pictured: a man clutches his chest with one hand and coughs into his fist

COPD Research Study

PRI- Los Alamitos is comparing two inhaler treatments on patients with Moderate to Severe COPD with cardiovascular disease or risk.

To qualify, you must:

  • Be 40-80 years old
  • Have Moderate to Severe COPD without an exacerbation within 8 weeks and no history of Asthma lifetime or lung cancer within 5 years
  • History of smoking
  • No history of Asthma
  • No history of Lung Cancer
  • Have pre-existing CVD or high-risk CVD conditions (Hypertension, Diabetes, Obesity, etc.)

Qualified participants may receive:

  • Study-related medication at no cost
  • Study-related medical exams at no cost
  • May receive compensation for time
pictured: a man clutches his chest with one hand and coughs into his fist

Why Participate?

Contribute to the advancement of medical knowledge and treatments, while receiving expert medical care under close supervision.

Experience

The M3 Wake Research Network has powered innovation with over 9,100 Successful Clinical Trials in patients from 6 months to 85 years.

Safety

Patient safety is paramount with strict protocols and ethical guidelines, minimizing risks and ensuring thorough monitoring throughout the trial.

Pharmacology Research Institute - Los Alamitos

Main Office
+1-714-827-3667

Our Hours
Mon: 8AM – 5PM
Tues: 8AM – 5PM
Wed: 8AM – 5PM
Thurs: 8AM – 5PM
Fri: 8AM – 2:30PM

Location
4281 Katella Avenue, Suite 230
Los Alamitos, CA 90720